author-photo

Petra Fettes

8

Papers

134

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

504 A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced stage solid tumors (Acronym: GDFATHER)

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced-stage solid tumors (ACRONYM: GDFATHER).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-beta 2),in subjects with open-angle glaucoma undergoing glaucoma filtration surgery

2017 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (26)
Main results of the First-In Human single ascending dose phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2) in glaucoma filtration surgery

2017 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (3)
A phase I First-In Human single ascending dose study of ISTH0036, a potent and selective antisense oligonucleotide targeting transforming growth factor beta 2 (TGF-β2) for the treatment of primary open-angle glaucoma

2016 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)